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Lewy body dementia includes dementia with Lewy bodies and Parkinson’s disease dementia and is characterized by transient clinical
symptoms such as fluctuating cognition, which might be driven by dysfunction of the intrinsic dynamic properties of the brain. In
this context we investigated whole-brain dynamics on a subsecond timescale in 42 Lewy body dementia compared to 27 Alzheimer’s
disease patients and 18 healthy controls using an EEG microstate analysis in a cross-sectional design. Microstates are transiently
stable brain topographies whose temporal characteristics provide insight into the brain’s dynamic repertoire. Our additional aim was
to explore what processes in the brain drive microstate dynamics. We therefore studied associations between microstate dynamics
and temporal aspects of large-scale cortical-basal ganglia-thalamic interactions using dynamic functional MRI measures given the
putative role of these subcortical areas in modulating widespread cortical function and their known vulnerability to Lewy body
pathology. Microstate duration was increased in Lewy body dementia for all microstate classes compared to Alzheimer’s disease
(P50.001) and healthy controls (P5 0.001), while microstate dynamics in Alzheimer’s disease were largely comparable to healthy
control levels, albeit with altered microstate topographies. Correspondingly, the number of distinct microstates per second was
reduced in Lewy body dementia compared to healthy controls (P50.001) and Alzheimer’s disease (P5 0.001). In the dementia
with Lewy bodies group, mean microstate duration was related to the severity of cognitive fluctuations ( = 0.56, PFDR = 0.038).
Additionally, mean microstate duration was negatively correlated with dynamic functional connectivity between the basal ganglia
(r =  0.53, P = 0.003) and thalamic networks (r =  0.38, P = 0.04) and large-scale cortical networks such as visual and motor
networks in Lewy body dementia. The results indicate a slowing of microstate dynamics and disturbances to the precise timing of
microstate sequences in Lewy body dementia, which might lead to a breakdown of the intricate dynamic properties of the brain,
thereby causing loss of flexibility and adaptability that is crucial for healthy brain functioning. When contrasted with the largely
intact microstate dynamics in Alzheimer’s disease, the alterations in dynamic properties in Lewy body dementia indicate a brain state
that is less responsive to environmental demands and might give rise to the apparent slowing in thinking and intermittent confusion
which typify Lewy body dementia. By using Lewy body dementia as a probe pathology we demonstrate a potential link between
dynamic functional MRI fluctuations and microstate dynamics, suggesting that dynamic interactions within the cortical-basal gang-
lia-thalamic loop might play a role in the modulation of EEG dynamics.
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Introduction
Lewy body dementia is an umbrella term that includes
both dementia with Lewy bodies and Parkinson’s disease
dementia and is the second most common cause of neuro-
degenerative dementia in older adults after Alzheimer’s dis-
ease (McKeith, 2007). In dementia with Lewy bodies
fluctuating cognition and attentional impairment are core
diagnostic features (McKeith et al., 2005, 2017), and these
are also characteristic of Parkinson’s disease dementia
(Aarsland et al., 2001; Ballard et al., 2002a, b; Emre
et al., 2007).
Fluctuating cognition in Lewy body dementia affects up
to 90% of patients and appears to be qualitatively distinct
from the less frequently seen fluctuations in other demen-
tias such as Alzheimer’s disease (Bradshaw et al., 2004;
Lee et al., 2012). In Lewy body dementia there appears
to be an interruption of awareness and attention that is
often associated with transient episodes of confusion and
communicative difficulties. Remission to near-normal cog-
nitive function can occur spontaneously in the absence of
clear environmental triggers suggesting that fluctuating
cognition in Lewy body dementia is internally driven and
that dynamic changes in brain activity play a role in its
aetiology (Ballard et al., 2001; Sourty et al., 2016).
Cognitive fluctuations can occur over days and hours,
but variations on shorter timescales occur, with a strong
association between subsecond reaction time variability
and cognitive fluctuations over longer time periods
(Walker, et al., 2000a). Often coupled with fluctuations
in Lewy body dementia is marked slowing of information
processing, and mental slowness, also known as brady-
phrenia, a phenomenon distinct from motor slowness
(Vlagsma et al., 2016).
It is not clear whether there is a pathological increase or
decrease in brain dynamical function associated with cog-
nitive fluctuations. In regard to the former, early studies in
Lewy body dementia posited that a second-by-second tem-
poral instability in the spectral power of the EEG of pa-
tients with dementia with Lewy bodies was associated with
the severity of cognitive fluctuations (Walker et al., 2000b;
Bonanni et al., 2008). In contrast, two recent studies from
our group have provided support for the counter-argument
of a decrease in brain dynamical function. In the first
study, we demonstrated that patients with Lewy body de-
mentia who have marked cognitive slowing or bradyphre-
nia (Firbank et al., 2018), had prolonged cognitive
processing on functional MRI; thus the cognitive aspects
of fluctuations may instead reflect a temporal mismatch
between the speed of environmental change and intrinsic
information processing speed. In our second study, we
investigated dynamic functional MRI network function in
dementia with Lewy bodies (Schumacher et al., 2018a) and
found a reduction of variability in global efficiency com-
pared to healthy controls, which we hypothesized was due
to an abnormal and temporally rigid global brain network
in dementia with Lewy bodies. These findings suggest that
a less dynamic brain may be apposite for the cognitive
phenotype of fluctuations that occurs in Lewy body de-
mentia. This is in alignment with the broader literature
which indicates that a dynamic brain, as evidenced by tem-
poral variability and flexibility of brain activity, is import-
ant for cognitive functioning (Deco et al., 2011; Garrett
et al., 2013; Zalesky et al., 2014) whereas less dynamic
brain activity is associated with worse performance on
cognitive tasks (McIntosh et al., 2008; Jia et al., 2014)
and ageing (Guitart-Masip et al., 2016; Grady and
Garrett, 2018).
Brain dynamics can be assessed with different methodol-
ogies and on different timescales: while functional MRI
allows the characterization of slower brain dynamics with
high spatial resolution, dynamical changes on a subsecond
timescale can be studied using EEG microstate analysis
(Michel and Koenig, 2017). Previous research has shown
that the EEG signal can be segmented into a number of
short, non-overlapping, quasi-stable topographies—the
microstates—that remain transiently stable for 80–120
ms before abruptly transitioning into a new state
(Lehmann et al., 1987; Khanna et al., 2015; Michel and
Koenig, 2017). Even though there is a large number of
possible topographies in multi-channel EEG, more than
70% of its variance can be explained by only a few distinct
and stereotypical topographies (Koenig et al., 1999). These
microstates have been described as the basic building
blocks of human information processing or the ‘atoms of
thought’ (Lehmann, 1990). Microstates have been shown
to influence cognition and perception (Milz et al., 2016;
Pedroni et al., 2017; Santarnecchi et al., 2017) and differ-
ent cognitive functions have been associated with specific
microstates (Britz et al., 2010). Furthermore, changes in
behavioural state have been related to changes in micro-
state dynamics: microstates tend to get shorter in drowsi-
ness and REM sleep compared to wakefulness (Cantero
et al., 1999), whereas deep sleep has been associated with
an increase in overall microstate duration (Brodbeck et al.,
2012). The time course of occurrence of individual micro-
state classes does not correlate with power in specific EEG
frequency bands (Britz et al., 2010). However, there might
be a relation between microstate dynamics and EEG oscil-
lations with some data suggesting that increased relative
power in higher frequencies might be weakly correlated
with shorter overall microstate duration (Koenig et al.,
2002).
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It has been shown that microstate temporal dynamics,
especially in terms of microstate duration, are important
for cognitive functioning (Van De Ville et al., 2010).
Furthermore, it has been suggested that investigating
temporal aspects of microstate sequences can provide
insight into the brain’s dynamic repertoire across differ-
ent timescales. Studying microstate dynamics on a sub-
second timescale can therefore provide information
about brain dynamics in general with implications for
fast and slow dynamic processes (Van De Ville et al.,
2010).
Thus, interrogation of microstate dynamics in Lewy
body dementia may provide a novel perspective in
understanding the basis of cognitive fluctuations and
more broadly the Lewy body dementia cognitive pheno-
type. These investigations form the first part of the
paper.
In the second part, we address potential mechanisms that
might be related to microstate transition and their disrup-
tion in Lewy body dementia. While there is evidence for a
relation between specific microstates and the well known
resting state networks that can be obtained from functional
MRI (Britz et al., 2010; Musso et al., 2010; Custo et al.,
2017), it remains unclear which processes in the brain are
related to the abrupt global transitions between different
microstates (Michel and Koenig, 2017). However, subcor-
tical-cortical networks represent one putative system which
could globally alter brain dynamics given their significant
and widespread cortico-petal connectivity. In particular,
both the thalamus and the basal ganglia have extensive
connections to various parts of the cortex and form part
of the cortical-basal ganglia-thalamic loop, which is an im-
portant contributor to large-scale network communication
within the brain (Bell and Shine, 2016). The thalamus has
been suggested to play a role in modulating the cortical
EEG signal (Lopes da Silva, 1991) and its activity has
been shown to relate to cortical microstate characteristics
(Schwab et al., 2015). From a Lewy body dementia per-
spective, structural and functional abnormalities of the thal-
amus are a common feature in Lewy body diseases (Watson
et al., 2017). In particular, microstructural changes and
cholinergic imbalance in the thalamus have been suggested
to play a role in the aetiology of cognitive fluctuations in
dementia with Lewy bodies (Pimlott et al., 2006; Delli
Pizzi, et al., 2015a). Similarly, dopaminergic dysfunction
of the basal ganglia is a hallmark of Lewy body diseases
(McKeith et al., 2007) and aberrant functional connectivity
of the basal ganglia network has been found in dementia
with Lewy bodies and Parkinson’s disease (Szewczyk-
Krolikowski et al., 2014; Rolinski et al., 2015;
Schumacher et al., 2018b). Both the basal ganglia and the
thalamic networks are therefore potential candidate net-
works whose dynamic interaction with cortical networks
might influence microstate dynamics in Lewy body
dementia.
In summary, we sought to test two main hypotheses: (i) a
less dynamic brain, as evidenced by slowing of microstate
dynamics is a feature of Lewy body dementia, which is
related to the cognitive phenotype, and in particular, cog-
nitive fluctuations; and (ii) disturbances in microstate dy-
namics in Lewy body dementia would be contingent upon a
loss of dynamics within cortical-basal ganglia-thalamic
connections.
Materials and methods
Participants
The study involved 96 participants who were over 60 years of
age. Forty-six were diagnosed with probable Lewy body de-
mentia (25 dementia with Lewy bodies and 21 Parkinson’s
disease dementia), 32 with probable Alzheimer’s disease, and
18 were age-matched healthy controls with no history of psy-
chiatric or neurological illness. Patients were recruited from the
local community-dwelling population who had been referred
to old age psychiatry and neurology services between 2010
and 2014. The study was approved by the local ethics com-
mittee and written informed consent was obtained from all
participants. Dementia diagnoses were performed independ-
ently by two experienced clinicians in alignment with the con-
sensus criteria for probable dementia with Lewy bodies
(McKeith et al., 2005), Parkinson’s disease dementia (Emre
et al., 2007), and Alzheimer’s disease (McKhann et al.,
2011). Patients who were taking dopaminergic medication
were assessed in the ‘ON’ motor state.
All participants underwent a detailed neurological and
neuropsychiatric assessment. Tests that were relevant to the
present study included the Mini-Mental State Examination
(MMSE) and Cambridge Cognitive Examination (CAMCOG)
as measures of global cognition, the Unified Parkinson’s
Disease Rating Scale (UPDRS) part III for the assessment of
Parkinsonian motor problems, and the Neuropsychiatric
Inventory (NPI) hallucination subscale, which was specifically
focussed on visual hallucination occurrence. For the assess-
ment of cognitive fluctuations we used the Clinician
Assessment of Fluctuation (CAF, Walker et al., 2000c),
which provides a global measure of the duration and fre-
quency of cognitive fluctuations and the Mayo Fluctuation
Scale (Ferman et al., 2004), which has two major phenotypic
dimensions of fluctuations: a cognitive-attention subscale and
an arousal-alertness subscale (Bliwise et al., 2014).
EEG acquisition and preprocessing
Resting state EEG recordings were acquired from all partici-
pants using Waveguard caps (ANT Neuro) comprising 128
sintered Ag/AgCl electrodes that were placed according to
the 10–5 system. Participants were seated during the recording
and were instructed to remain awake, but keep their eyes
closed. Electrode impedance was kept below 5 kV and 150 s
of continuous EEG data were recorded at a sampling fre-
quency of 1024 Hz. The ground electrode was attached to
the right clavicle and all EEG channels were referenced to Fz
during recording.
Preprocessing of EEG data was performed blinded to group
membership and methods applied were the same as described
in Peraza et al. (2018). Briefly, data were filtered between 0.3
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to 54Hz using a second order Butterworth filter, noisy EEG
segments with artefacts affecting all channels were deleted, and
independent component analysis was used for artefact re-
moval. Data were then recomputed against the average refer-
ence, bandpass filtered between 2 and 20Hz, and split into
non-overlapping epochs of 2 s. For each participant the first
30 2-s long artefact-free epochs were selected for the micro-
state analysis. Four Alzheimer’s disease and five Parkinson’s
disease dementia patients with 530 artefact-free epochs were
excluded from further analysis. This resulted in 18 healthy
controls, 27 patients with Alzheimer’s disease, and 42 patients
with Lewy body dementia (25 dementia with Lewy bodies and
17 Parkinson’s disease dementia) for further analysis.
Microstate analysis
The microstate analysis was conducted using the Cartool soft-
ware (Brunet et al., 2011) and functions from the EEGLAB
plugin for microstates (http://www.thomaskoenig.ch/index.
php/software/microstates-in-eeglab) in MATLAB R2017a. As
a first step, the global field power (GFP) was calculated,
which is equivalent to the spatial standard deviation of the
average-referenced signal across all electrodes and whose
local maxima represent instants of highest field strength
(Lehmann and Skrandies, 1980). EEG topographies tend to
remain stable during periods of high GFP and change rapidly
around the local minima of the GFP (Lehmann et al., 1987).
Thus, topographies at GFP peaks are representative of topo-
graphies at surrounding time points and restricting the micro-
state analysis to these GFP peaks provides optimal topographic
signal-to-noise ratios (Lehmann et al., 1987). For each subject
separately, topographies at GFP peaks were subjected to a
topographic atomize and agglomerate hierarchical clustering
(TAAHC) algorithm (Murray et al., 2008) (Fig. 1A). The op-
timal number of microstate classes k was determined for each
participant individually using the meta-criterion described in
Custo et al. (2017), testing the entire range of 1 to 12 classes.
The individual maps were then averaged across all participants
within each group using a permutation algorithm (Koenig
et al., 1999) and overall mean maps across all participants
were obtained by averaging the group-specific average maps
across groups (Fig. 1B).
The group microstate maps were then fit back to the original
data at GFP peaks assigning each GFP peak to one microstate
class based on the maximal spatial correlation between topo-
graphies (Fig. 1C). Microstate labels for data points between
GFP peaks were interpolated with microstates starting and
ending halfway between two GFP peaks. Potentially truncated
microstates at the beginning and end of each epoch were
excluded from the analysis. Microstate duration was then cal-
culated as the time during which all successive maps were as-
signed to the same microstate. Additionally, the mean number
of occurrences of each microstate class per second (microstate
occurrence) and the percentage of total analysis time covered
by each microstate (microstate coverage) were calculated.
Furthermore, transition probabilities were analysed. Details
are available in the Supplementary material.
Microstate statistics
The topographies of the different microstate classes were com-
pared between the groups using TANOVA (topographical
analysis of variance) implemented in the Ragu software
(Koenig et al., 2011). For this, a non-parametric randomiza-
tion test was performed on global map dissimilarity with a
within-subject factor of microstate class and a between-subject
factor of group.
Microstate duration, occurrence, coverage, and observed
transition probabilities were compared between the groups
using separate MANOVAs (multivariate analyses of variance)
in SPSS (Statistical Package for the Social Sciences v23, IBM).
In the case of an overall significant test, follow-up univariate
ANOVAs were performed to determine which microstate
classes showed group differences followed by post hoc tests
with Bonferroni-correction for multiple comparisons.
Spearman’s correlations between mean microstate duration
and the Mayo fluctuation scale (overall score, cognitive sub-
score, and arousal subscore) were tested in the combined Lewy
body dementia group as well as in the two subgroups separ-
ately. P-values were FDR (false discovery rate)-corrected for
multiple comparisons. To check whether these correlations
were influenced by dopaminergic medication, a linear regres-
sion analysis was also performed adding levodopa equivalent
daily dose (LEDD, Tomlinson et al., 2010) as a covariate in
the model. Supplementary correlation analyses were performed
for the CAF score in the Lewy body dementia group and for
global cognitive scores (MMSE and CAMCOG) across the
dementia groups.
As an additional exploratory analysis, Spearman’s correl-
ations were calculated in the Lewy body dementia group be-
tween Mayo fluctuation scores and microstate duration for
each microstate class separately.
Frequency analysis
A consistent finding from previous EEG studies in Lewy body
dementia is the observation of a general slowing of oscillatory
EEG activity as evidenced by a slowing of the dominant fre-
quency in posterior regions compared to healthy controls and
Alzheimer’s disease patients (Cromarty et al., 2015; Bonanni
et al., 2016; Peraza et al., 2018; Stylianou et al., 2018). To
investigate the relationship between this general EEG slowing
and microstate temporal characteristics, we calculated the
Pearson’s correlation between dominant frequency and mean
microstate duration and the number of GFP peaks per second
in the Lewy body dementia group. To assess posterior EEG
slowing, dominant frequency was estimated by averaging the
signal from all occipital channels (PO9, PO7, POO9h, PO5,
O1, PO3, POO3h, OI1h, POz, Oz, PO4, POO4h, PO6, O2,
OI2h, PO8, POO10h, PO10) and estimating power spectral
density with Welch’s periodogram (Peraza et al., 2018).
Dominant frequency was defined as the frequency bin in the
power spectrum with the highest power between 4 and 15Hz,
and for each participant the mean dominant frequency across
the whole EEG timecourse was estimated. In addition to only
using occipital channels, the dominant frequency analysis was
repeated using all channels.
Additionally, the power from all electrodes was estimated
for different frequency bands (delta: 0.5–4Hz, theta:
4–5.5Hz, high-theta: 5.5–8Hz, alpha: 8–13, and beta:
13–30) and correlated with mean microstate duration and
number of GFP peaks per second.
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Functional MRI dynamic connectivity
Resting state functional MRI was recorded from a subset of
the participants included in the EEG study (non-concurrent,
performed between 1 and 3 weeks apart). This subset
comprised 12 healthy controls, 14 patients with Alzheimer’s
disease, and 29 patients with Lewy body dementia (17 demen-
tia with Lewy bodies and 12 Parkinson’s disease dementia).
Details on acquisition and preprocessing can be found in
Schumacher et al. (2018a). The dynamic connectivity analysis
Figure 1 Microstate analysis methods. (A) For each subject, data at global maxima of the GFP is clustered using the TAAHC algorithm to
obtain individual microstate maps. (B) The individual maps are combined to obtain group maps within each clinical group using a permutation
algorithm. (C) Group maps are fit back to the data at GFP peaks assigning each GFP peak to the microstate class with the highest topographical
correlation. Microstates in-between GFP peaks are interpolated. AD = Alzheimer’s disease; HC = healthy controls; LBD = Lewy body dementia;
TAAHC = topographic atomize and agglomerate hierarchical clustering.
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followed the same steps as described by Allen et al. (2014) and
Schumacher et al. (2018a). Briefly, dynamic connectivity was
calculated using a sliding-window approach to assess how the
functional connectivity between different resting state networks
changed over time (see Supplementary material for a more
detailed description). In the present analysis, given our a
priori hypothesis, we focussed on dynamic connectivity
between two subcortical networks (basal ganglia and thalamic
networks) and all other networks (see Supplementary Table 12
for a list of all included networks and Fig. 5 for a depiction of
the network maps).
Combining EEG microstates and
dynamic functional MRI connectivity
The mean variability of connectivity (standard deviation over
time) between the two subcortical networks of interest—basal
ganglia and thalamus—and all other networks was calculated
and correlated with mean microstate duration in each group
separately using Pearson’s correlations. To assess which of the
individual network connections contributed most to the overall
correlation, we correlated mean microstate duration with the
dynamic connectivity of each connection separately, correcting
the resulting P-values for multiple comparisons using FDR cor-
rection. The same analysis was performed for the duration of
each microstate class separately (Supplementary Tables 17 and
18).
Data availability
The data that support the findings of this study are available
from the corresponding author, upon reasonable request.
Results
Demographics
Supplementary Table 1 shows a comparison of clinical
symptoms between the two Lewy body groups. Both sub-
groups were matched in terms of age, gender, overall cog-
nition, the percentage of patients taking cholinesterase
inhibitors, and cognitive fluctuation and visual hallucin-
ation severity. More Parkinson’s disease dementia patients
were taking dopaminergic medication and they had worse
Parkinsonism than the patients with dementia with Lewy
bodies. Dementia with Lewy bodies and Parkinson’s disease
dementia patients were combined into one Lewy body de-
mentia group as preliminary analyses showed that there
were no group differences with respect to microstate char-
acteristics (Supplementary Table 2).
Healthy control, Alzheimer’s disease, and Lewy body de-
mentia participants were similar in age and gender
(Table 1). Additionally, the two dementia groups did not
differ significantly in terms of dementia duration. However,
the Lewy body dementia group was significantly less im-
paired in terms of overall cognition (MMSE and
CAMCOG) compared to the Alzheimer’s disease group.
The percentage of patients taking cholinesterase inhibitors
did not differ between the dementia groups whereas, as
expected, significantly more Lewy body dementia patients
were taking dopaminergic medication compared to the
Alzheimer’s disease group. The Lewy body dementia pa-
tients were more impaired than the Alzheimer’s disease pa-
tients with respect to the core Lewy body dementia
symptoms of parkinsonism, cognitive fluctuations, and
visual hallucinations.
To ensure that the difference in overall cognition between
the two dementia groups did not influence the results, all
analyses described below were rerun with Alzheimer’s dis-
ease and Lewy body dementia subgroups that were
matched for MMSE and CAMCOG (Supplementary
material).
Demographics for those participants that were included
in the combined EEG-functional MRI analysis are shown in
Supplementary Table 13. All three groups were matched
for age and gender, while the two dementia groups were
matched in terms of overall cognition.
Cluster evaluation
The optimal number of microstate classes for each partici-
pant was determined to be between four and eight. The
median within each clinical group as well as the overall
median was five, with no significant differences between
the groups [Kruskal-Wallis ANOVA, H(2) = 0.93,
P = 0.63]. The number of microstate classes was therefore
set to five for all subsequent analyses.
Across all participants the mean global explained vari-
ance of five microstate classes was 70% [standard deviation
(SD) = 6%]. The mean and standard deviation in each
group was 71% (SD = 8%) for healthy controls, 68%
(SD = 5%) for Alzheimer’s disease, and 71% (SD = 5%)
for Lewy body dementia. A univariate ANOVA showed
that there were no significant group differences
[F(2,84) = 3.01, P = 0.06]. Nevertheless, as there was a
trend for lower explained variance in the Alzheimer’s dis-
ease group compared to Lewy body dementia, group com-
parisons of microstate characteristics were repeated
including global explained variance as covariate
(Supplementary material). This analysis indicated that
including this covariate did not change the overall signifi-
cance of the results regarding temporal microstate
characteristics.
Microstate topographies
Group microstate maps and the overall maps across all
participants are shown in Fig. 2. Microstate classes A to
D corresponded well to the canonical microstate maps that
have been reported in the literature (Michel and Koenig,
2017). There was an additional microstate class E that re-
sembles a slightly lateralized version of class D and might
be comparable to the deviant microstate topography of
class C that has been described by Grieder et al. (2016)
in a group of patients with semantic dementia.
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The overall TANOVA revealed a significant main effect
of microstate class (P = 0.0002) and a main effect of group
(P = 0.0002), but no interaction between the two factors
(P = 0.45). Follow-up TANOVAs for each microstate class
showed that the Alzheimer’s disease topographies were dif-
ferent from both the healthy controls and Lewy body de-
mentia topographies for all microstate classes (Fig. 2 and
Supplementary Tables 6 and 7). In contrast, there were no
Table 1 Demographic and clinical variables
Healthy controls (n = 18) Alzheimer’s disease (n = 27) LBD (n = 42) Between-group
differences
Male: female 11:7 20:7 36:6 2 = 4.5, P = 0.11a
Age 76.3 (5.5) 74.9 (7.0) 74.8 (6.4) F(2,84) = 0.35, P = 0.70b
AChEI - 25 36 2 = 0.76, P = 0.38c
PD meds - 1 29 2 = 28.6, P5 0.001c
Duration - 3.9 (2.1)f 3.2 (2.1)g U = 399, P = 0.12d
MMSE 29.2 (0.9) 20.7 (4.3) 23.1 (3.7) t(67) = 2.51, P = 0.01e
CAMCOG 96.7 (3.7) 67.4 (15.7) 75.7 (11.1) t(67) = 2.57, P = 0.01e
UPDRS III 1.3 (1.5) 2.4 (3.0) 20.4 (8.5) t(67) = 10.6, P5 0.001e
CAF total - 0.38 (0.98)g 5.0 (4.3)h t(64) = 5.31, P5 0.001e
Mayo total - 9.4 (4.7)g 14.0 (5.7)h t(64) = 3.41, P = 0.001e
Mayo cogn - 1.9 (1.8)g 2.8 (1.8)h t(64) = 2.06, P = 0.043e
NPI total - 6.8 (6.6)g 14.3 (10.5)i t(65) = 3.23, P = 0.002e
NPI hall - 0.04 (0.20)g 1.9 (2.0)i t(65) = 4.90, P5 0.001e
Values are mean (SD).
AChEI = number of patients taking acetylcholinesterase inhibitors; CAF total = Clinician Assessment of Fluctuation total score; CAMCOG = Cambridge Cognitive Examination;
Duration = duration of cognitive symptoms in years; LBD = Lewy body dementia; Mayo total = Mayo Fluctuations Scale; Mayo cognitive = Mayo Fluctuation cognitive subscale;
MMSE = Mini-Mental State Examination; PD meds = number of patients taking dopaminergic medication for the management of Parkinson’s disease symptoms; UPDRS III = Unified
Parkinson’s Disease Rating Scale III (motor subsection); NPI = Neuropsychiatric Inventory; NPI hall = NPI hallucination subscore.
aChi-square test healthy controls, Alzheimer’s disease, Lewy body dementia.
bOne-way ANOVA healthy controls, Alzheimer’s disease, Lewy body dementia.
cChi-square test Alzheimer’s disease, Lewy body dementia.
dMann Whitney U-test Alzheimer’s disease, Lewy body dementia.
eStudent’s t-test Alzheimer’s disease, Lewy body dementia.
fn = 25, gn = 26, hn = 40, in = 41.
Figure 2 Microstate class topographies. P-values result from comparing the group topographies between groups using TANOVA. For the
comparison between healthy controls and Lewy body dementia all P -values were 40.1. AD = Alzheimer’s disease; HC = healthy controls;
LBD = Lewy body dementia.
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significant differences between healthy controls and Lewy
body dementia topographies for any microstate class.
Microstate temporal characteristics
The mean number of GFP peaks per second was 21.3 in
healthy controls, 19.7 in Alzheimer’s disease, and 17.2 in
Lewy body dementia. There was a significant difference
between groups [univariate ANOVA, F(2,84) = 26.6,
P5 0.001] with Bonferroni-corrected post hoc tests
demonstrating that the number of GFP peaks was lower
in Alzheimer’s disease compared to controls (P = 0.034),
and lower in Lewy body dementia compared to controls
(P50.001) and Alzheimer’s disease (P5 0.001). To con-
firm that the group differences in microstate duration and
occurrence reported below were not merely due to differ-
ences in the number of GFP peaks we repeated the micro-
state analysis, this time fitting the group maps to all
individual data points instead of restricting the fitting
procedure to data at GFP peaks (Supplementary
material).
Across all microstate classes, mean microstate duration
was 65ms in controls, 67ms in Alzheimer’s disease pa-
tients, and 77ms in the Lewy body dementia group. A
univariate ANOVA followed by post hoc group compari-
sons showed that mean microstate duration was increased
in Lewy body dementia compared to controls and
Alzheimer’s disease with no significant difference between
Alzheimer’s disease and controls (Fig. 3 and Table 2).
Correspondingly, the mean number of unique microstate
occurrences per second was 16 in controls, 15.5 in
Alzheimer’s disease, and 13.5 in Lewy body dementia.
Univariate ANOVA and post hoc tests showed that the
number of unique microstate occurrences per second was
significantly decreased in Lewy body dementia compared to
controls and Alzheimer’s disease with no significant differ-
ence between Alzheimer’s disease and controls (Fig. 3 and
Table 3). These results did not change when fitting all in-
dividual time points (Supplementary material).
Multivariate ANOVAs followed by post hoc univariate
ANOVAs were conducted to test for group differences in
mean microstate duration and occurrence for microstate
classes A to E (Fig. 3 and Tables 2 and 3). Microstate A
duration was increased in both dementia groups compared
to controls with a trend for a further increase in Lewy body
dementia compared to Alzheimer’s disease. Occurrence of
microstate A was reduced in Lewy body dementia com-
pared to controls and Alzheimer’s disease with no differ-
ence between controls and Alzheimer’s disease. The other
microstates (B to E) showed similar patterns in terms of
duration with increased duration in Lewy body dementia
compared to Alzheimer’s disease and controls and no dif-
ference between Alzheimer’s disease and controls. The oc-
currence of microstates B and C was decreased in Lewy
Figure 3 Temporal microstate characteristics. Group comparison of microstate duration and occurrence per second overall and for each
microstate class separately. P-values result from pairwise post hoc tests following univariate ANOVAs. See Tables 2 and 3 for detailed information
on statistics. AD = Alzheimer’s disease; HC = healthy controls; LBD = Lewy body dementia.
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body dementia compared to controls and Alzheimer’s dis-
ease with no difference between controls and Alzheimer’s
disease. In contrast, microstate D occurrence was only
reduced in Lewy body dementia compared to controls,
but there was no difference between controls and
Alzheimer’s disease and between the dementia groups.
The occurrence of microstate E was reduced in both de-
mentia groups compared to controls with no difference be-
tween the dementia groups.
Repeating the group comparison analyses with matched
dementia groups did not change the overall results, but
enhanced some of the differences between the Alzheimer’s
disease and Lewy body dementia groups (Supplementary
Tables 4 and 5).
Microstate coverage, i.e. the percentage of total analysis
time spent within each microstate, was not different
between the groups [MANOVA, F(8,164) = 1.79,
P = 0.08]; this was further confirmed with univariate post
hoc analysis (Supplementary Table 8).
Transition probabilities were found to be non-random in
all three groups and there were no group differences in
transition probabilities (Supplementary material).
Clinical correlations
Figure 4 shows results from Spearman’s correlations be-
tween the Mayo fluctuation scales and mean microstate
duration in the dementia with Lewy bodies patients with
P-values FDR-corrected for multiple comparisons. There
was a positive correlation between mean microstate dur-
ation and the Mayo total score in the combined Lewy
body dementia group ( = 0.36, PFDR = 0.06), which was
Table 2 Microstate duration for microstate classes A to E and the three clinical groups, and results from group
comparison using univariate ANOVAs and pairwise post hoc tests
Healthy controls Alzheimer’s disease Lewy body dementia ANOVA Post hoc (P-value)
HC-AD HC-LBD AD-LBD
Mean 64.7 66.6 77.0 F(2,84) = 15.5, 1.0 50.001 50.001
[60.2,69.1] [63.0,70.3] [74.2,79.9] P5 0.001
A 56.6 65.4 71.0 F(2,84) = 14.2 0.01 50.001 0.06
[52.1,61.1] [61.7,69.1] [68.0,73.9] P5 0.001
B 57.6 62.3 71.0 F(2,84) = 12.9 0.38 50.001 0.003
[52.9,62.4] [58.5,66.2] [67.9,74.1] P5 0.001
C 60.8 66.9 75.7 F(2,84) = 16.0 0.14 50.001 0.002
[56.1,65.4] [63.1,70.7] [72.7,78.8] P5 0.001
D 64.2 65.6 80.1 F(2,84) = 13.9 1.0 50.001 50.001
[57.9,70.4] [60.5,70.7] [76.0,84.2] P5 0.001
E 67.6 66.7 77.2 F(2,84) = 5.7 1.0 0.05 0.01
[61.0,74.2] [61.3,72.1] [72.9,81.5] P = 0.005
Values are mean [95% confidence interval, CI].
AD = Alzheimer’s disease; HC = healthy controls; LBD = Lewy body dementia.
Post hoc P-values are Bonferroni-corrected for multiple comparisons.
Table 3 Microstate occurrence per second for microstate classes A to E and the three clinical groups, and results
from group comparison using univariate ANOVAs and pairwise post hoc tests
Healthy controls Alzheimer’s disease Lewy body dementia ANOVA Post hoc (P-value)
HC-AD HC-LBD AD-LBD
Mean 16.1 15.5 13.5 F(2,84) = 15.1 0.99 50.001 50.001
[15.2,17.0] [14.8,16.3] [12.9,14.1] P5 0.001
A 3.0 3.1 2.6 F(2,84) = 5.6 1.0 0.17 0.005
[2.6,3.3] [2.9,3.4] [2.4,2.8] P = 0.005
B 3.1 2.9 2.5 F(2,84) = 8.3 0.87 0.001 0.01
[2.8,3.3] [2.7,3.1] [2.3,2.7] P5 0.001
C 3.2 3.3 2.7 F(2,84) = 8.2 1.0 0.03 50.001
[2.9,3.4] [3.1,3.5] [2.5,2.9] P5 0.001
D 3.4 3.2 3.0 F(2,84) = 4.3 0.58 0.02 0.31
[3.1,3.7] [3.0,3.4] [2.8,3.1] P = 0.016
E 3.5 3.0 2.8 F(2,84) = 10.8 0.02 50.001 0.16
[3.2,3.8] [2.8,3.3] [2.6,2.9] P5 0.001
Values are mean [95% confidence interval, CI]. Post hoc P-values are Bonferroni-corrected for multiple comparisons.
AD = Alzheimer’s disease; HC = healthy controls; LBD = Lewy body dementia.
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mainly driven by the dementia with Lewy bodies patients
( = 0.56, PFDR = 0.038) and was not present in the
Parkinson’s disease dementia group (P4 0.1). A similar
pattern was observed for the Mayo cognitive subscale
whereas correlations were weaker for the Mayo arousal
subscale (Fig. 4 and Supplementary Table 10). There
were non-significant trend associations with CAF total
score and CAF duration score with mean microstate dur-
ation in the dementia with Lewy bodies group (P4 0.10).
A linear regression analysis with LEDD as covariate indi-
cated that the covariate did not have a significant effect on
the correlation between the Mayo total score and mean
microstate duration in the dementia with Lewy bodies
group (P = 0.55).
When considering each microstate class separately in the
Lewy body dementia group, the Mayo total score and the
Mayo cognitive subscore were positively correlated with
duration of microstates A–C and E while there was no
significant correlation with duration of microstate D
(Supplementary Table 11). Again, these correlations were
mainly driven by the dementia with Lewy bodies group and
were not significant in the Parkinson’s disease dementia
patients.
Frequency analysis
There were weak, but non-significant negative correlations
between dominant frequency and mean microstate dur-
ation in the Lewy body dementia group when estimating
dominant frequency only from occipital channels
(r = 0.25, P = 0.11) or using all electrodes (r = 0.25,
P = 0.12). In contrast, the number of GFP peaks per
second was significantly positively correlated with domin-
ant frequency from occipital electrodes (r = 0.41,
P = 0.007) and when considering all electrodes (r = 0.36,
P = 0.02).
Power within the delta band was positively correlated
with mean microstate duration (r = 0.35, P = 0.02) and
negatively correlated with the number of GFP peaks per
second (r = 0.6, P5 0.001) (Supplementary Table 12).
In contrast, beta band power was negatively correlated
with mean microstate duration (r = 0.58, P5 0.001)
and positively correlated with the number of GFP peaks
per second (r = 0.71, P50.001). Additionally, alpha
power was positively correlated with the number of GFP
peaks per second (r = 0.45, P = 0.003).
Relation between dynamic
connectivity and microstate duration
In the Lewy body dementia group, mean variability of
connectivity between the basal ganglia network and all
other networks was negatively related to mean microstate
duration (r = 0.53, P = 0.003; Fig. 5A). When consider-
ing each connection separately, there were six networks
whose dynamic interaction with the basal ganglia network
was negatively correlated with mean microstate duration:
two motor networks (right motor network and medial
sensorimotor network), three visual networks (medial
visual network, superior visual network, and lingual
gyrus network) and the default mode network 2 (all
P50.05, uncorrected) (Supplementary Table 15). After
correcting for multiple comparisons, the dynamic inter-
action between the basal ganglia network and the medial
visual network was still significantly correlated with mean
microstate duration.
For the thalamic network, overall dynamic connectivity
was also negatively related to mean microstate duration
(r = 0.38, P = 0.044; Fig. 5B). When considering each
connection separately, there were four networks whose dy-
namic interaction with the thalamic network was negatively
correlated with mean microstate duration: the insular net-
work 2, the lateral sensorimotor network, the occipital pole
network, and the cerebellar network 2 (all P5 0.05, un-
corrected, see Supplementary Table 16). After correcting
Figure 4 Clinical correlations. Spearman’s correlations between mean microstate duration and Mayo fluctuation scores in the dementia with
Lewy bodies group. P-values are FDR-corrected for multiple comparisons. Mayo arousal = Mayo Fluctuations arousal subscale; Mayo total = Mayo
Fluctuations Scale; Mayo cognitive = Mayo Fluctuation cognitive subscale.
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for multiple comparisons, the dynamic interaction between
the thalamic network and the lateral sensorimotor network
was still significantly correlated with mean microstate
duration.
Supplementary Fig. 2 shows correlations between overall
dynamic connectivity of basal ganglia and thalamic net-
works in healthy controls and Alzheimer’s disease, none
of which were significant.
Figure 5 Relation between microstate dynamics and dynamic functional MRI connectivity. Results from Pearson’s correlation
analysis between mean microstate duration and dynamic functional connectivity of (A) the basal ganglia network (BGN) and (B) the thalamic
network (THN) in the Lewy body dementia group. The plots on the right show results from correlating mean microstate duration with each
individual network connection. Grey arrows indicate significant correlations at an uncorrected threshold of P5 0.05 and red arrows indicate
connections that survive Bonferroni correction for multiple comparisons (all correlations that are marked with an arrow were negative). All
correlation coefficients and corresponding P-values are shown in Supplementary Tables 15 and 16 and all network names and locations can be
found in Supplementary Table 14.
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Discussion
In this study, we investigated changes in brain dynamics in
Lewy body dementia compared to healthy ageing and
Alzheimer’s disease using an EEG microstate analysis to
assess temporal characteristics of brain activity on a sub-
second timescale and the relation between microstate dy-
namics and large-scale functional MRI network dynamics
within the cortical-basal ganglia-thalamic loop.
Microstate dynamics
We found a marked and generalized slowing of microstate
dynamics in Lewy body dementia compared to both
healthy controls and Alzheimer’s disease patients while
temporal microstate characteristics in Alzheimer’s disease
were largely comparable to healthy control levels. Patients
with Lewy body dementia stayed in the same microstate
class for longer consecutive periods of time and switched
less frequently between different states than healthy con-
trols and Alzheimer’s disease patients. This was not specific
to a certain microstate class as reported for other diseases
(Koenig et al., 1999; Kikuchi et al., 2011; Nishida et al.,
2013), but rather a general pattern observed for all classes,
which indicates that general microstate timing mechanisms
are affected in Lewy body dementia.
The observed slowing of microstate dynamics in Lewy
body dementia indicates a relative loss of resting state
brain variability compared to healthy ageing and
Alzheimer’s disease and is in line with our previous obser-
vation of a loss of brain network flexibility in dementia
with Lewy bodies as evidenced by dynamic functional
MRI network analysis (Schumacher et al., 2018a). The im-
portance of variability in the brain has been confirmed in
many studies (see Garrett et al., 2013 for a review) relating
less variability to ageing (Guitart-Masip et al., 2016; Grady
and Garrett, 2018) and poorer performance on various
cognitive tests (McIntosh et al., 2008; Jia et al., 2014).
Reduced microstate dynamics in Lewy body dementia
could therefore be an indicator of less flexible, and ineffect-
ive, brain functioning.
Apart from being an indicator of brain variability at rest,
microstates show elaborate dynamic properties that are im-
portant for optimal brain functioning. In the healthy brain,
microstate sequences have been shown to exhibit scale-free
or fractal dynamics, i.e. the microstate time course is stat-
istically self-similar across multiple timescales (Van De Ville
et al., 2010). The observation of scale-free properties in a
dynamic system indicates that the system operates near a
point of criticality, fluctuating around a phase transition
(Tagliazucchi et al., 2012; Hesse and Gross, 2014). This
state makes the system optimally adaptable enabling it to
respond to incoming information and unpredictable stimuli
by providing a self-organizing mechanism and preventing
the emergence of excessive periodicity at the same time
(Goldberger et al., 2002). The extent of scale-free dynamics
can also be used as an indicator of a system’s dynamic
complexity with a reduction in fractal dimension indicating
a loss of system complexity (Zappasodi et al., 2014). In the
context of microstate sequences, it was shown that scale-
free properties are preserved when the temporal sequence
of the microstate labels is randomized, whereas these long-
range dependencies are lost when equalizing microstate
duration (Van De Ville et al., 2010). This shows that the
exact sequence of microstate classes is not crucial, but
rather their duration seems to be the key parameter for
the emergence of scale-free dynamics and thus optimal net-
work properties. The observed abnormalities in microstate
timing in Lewy body dementia, we would therefore argue,
could have significant consequences for the functioning of
the whole brain network by potentially disturbing its intri-
cate fractal dynamics. However, further work is required to
assess the effect of the observed increase in microstate dur-
ation in Lewy body dementia on the fractality of the dy-
namic system more directly.
We found a correlation between the severity of cognitive
fluctuations and temporal microstate abnormalities in the
dementia with Lewy bodies group suggesting that more
severe cognitive fluctuations are related to a greater slowing
of microstate dynamics; this relationship was stronger for
the cognitive/attentional dimensions of cognitive fluctu-
ations as opposed to arousal or alertness (Bliwise et al.,
2014). Additionally, we observed largely intact microstate
dynamics in an Alzheimer’s disease group of comparable
dementia severity. This indicates that the alterations in dy-
namic properties in Lewy body dementia might drive the
brain network away from the point of criticality that is
important for healthy cognitive functioning towards a
state that allows for the emergence of cognitive symptoms
that are specific to Lewy body dementia such as fluctuating
cognition (Ferman et al., 2004). However, the relationship
between microstate dynamics and the severity of cognitive
fluctuations was specific to the dementia with Lewy bodies
group and was not observed in the Parkinson’s disease de-
mentia patients. This might suggest a different aetiology of
cognitive fluctuations in these patients even though clinic-
ally they present very similarly (Ballard et al., 2002a, b;
Varanese et al., 2010). Some of this may also relate to
difficulties in assessing fluctuating cognition in patients
with more advanced Parkinson’s disease due to the con-
founding presence of motor fluctuations or the more sig-
nificant levodopa load in these patients, although notably
we did not see any association between LEDD and micro-
state metrics.
The observation of largely preserved microstate dynamics
in Alzheimer’s disease agrees with two previous studies that
similarly reported no differences between Alzheimer’s dis-
ease patients and age-matched controls in terms of the
microstates’ temporal characteristics (Nishida et al., 2013;
Grieder et al., 2016). In contrast to our results, Nishida
et al. (2013) found that transition probabilities in
Alzheimer’s disease patients showed a pattern that was
compatible with random transitions. Alzheimer’s patients
in this previous study showed a comparable level of
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cognitive impairment to our patients. However, patients in
the Nishida et al. (2013) study were not taking any cho-
linergic medications whereas the large majority of our pa-
tients were on cholinesterase inhibitors, which have been
shown to alter resting state EEG characteristics in
Alzheimer’s disease (Babiloni et al., 2013) and might thus
be an explanation for the different results.
An alteration in the topographical structure of the micro-
states was only observed in Alzheimer’s disease while topo-
graphies in Lewy body dementia did not differ significantly
from healthy controls. This highlights again that it is pri-
marily microstate dynamics that seem to be affected by
Lewy body dementia. In contrast, the change in microstate
topographies in Alzheimer’s disease might be due to the
greater structural abnormalities in this condition compared
to Lewy body dementia (Mak et al., 2015a, b).
With respect to previous EEG studies in Lewy body de-
mentia, a general slowing of oscillatory EEG activity as
evidenced by a slowing of the dominant frequency in pos-
terior regions is a well-established finding (Cromarty et al.,
2015; Bonanni et al., 2016; Peraza et al., 2018; Stylianou
et al., 2018) and thus it could be argued that this global
change is driving our observed group differences in micro-
state dynamics. However, when testing the correlation be-
tween dominant frequency and mean microstate duration
in the Lewy body dementia group, we only found a weak
negative correlation, which was not statistically significant.
This indicates that while generalized EEG slowing might
partially contribute to microstate slowing, it does not
fully explain the relative loss of microstate dynamics in
Lewy body dementia. In contrast, the number of GFP
peaks per second was positively correlated with dominant
frequency in the Lewy body dementia group indicating that
the group differences in the number of GFP peaks per
second were influenced by differences in dominant fre-
quency between the groups (Lehmann et al., 1987; Peraza
et al., 2018). However, we showed that, overall, our results
can be replicated when fitting the microstates on all data
instead of the GFP peaks, further suggesting that the well
established finding of EEG slowing in Lewy body dementia
is not equivalent to the slowing of microstate dynamics that
we describe here. Nevertheless, the frequency analysis indi-
cated that there is a potential inter-relation between a shift
of EEG power from higher to lower frequencies and a
slowing of microstate dynamics as previously suggested
by Koenig et al. (2002). Further work is therefore required
to understand the exact relationship between microstate
slowing and general EEG slowing in Lewy body dementia.
Origins of microstate disturbances in
Lewy body dementia
Even though previous studies have found a link between
the rapidly changing EEG microstate sequences and slower
changes of the functional MRI signal (Britz et al., 2010;
Musso et al., 2010; Custo et al., 2017), it remains largely
unknown which processes in the brain might be responsible
for the emergence of the precise microstate timing and
hence their complex dynamic properties (Michel and
Koenig, 2017). In our study, we found an association be-
tween less dynamic connectivity between basal ganglia and
thalamic networks with large-scale cortical networks and a
loss of microstate dynamics in Lewy body dementia. These
findings provide, for the first time, evidence to suggest that
the dynamic interaction within the cortical-basal ganglia-
thalamic loop plays a part in the modulation of global
microstate dynamics. This is relevant from a Lewy body
dementia perspective as thalamic and basal ganglia dys-
function is a hallmark of Lewy body diseases (Pimlott
et al., 2006; McKeith et al., 2007; Delli Pizzi 2015a, b;
Watson et al., 2017). Our results therefore support the
conjecture that key subcortical abnormalities have broader
impacts on the overall functioning of the whole-brain net-
work in Lewy body dementia: we speculate that structural
and functional changes within subcortical structures asso-
ciated with Lewy body disease contribute to an impairment
in the dynamic interaction between these subcortical and
large-scale cortical networks. This in turn might lead to the
loss of crucial dynamic properties and hence a reduction in
brain adaptability and efficiency as described above.
Additionally, these results provide a possible explanation
for how strategic pathology in subcortical structures in
Lewy body dementia can have more widespread impact
on cognitive functions and symptom manifestation, espe-
cially with respect to cognitive fluctuations (Delli Pizzi
et al., 2015a).
Apart from being relevant to our understanding of brain
abnormalities in Lewy body dementia, the present study
might also help to further our more general understanding
of microstate dynamics by providing a first hint at how
dynamic microstate properties might be modulated by sub-
cortical-cortical dynamics. This has wider implications for a
better mechanistic understanding of other diseases that are
characterized by microstate abnormalities such as schizo-
phrenia and depression (Strik et al., 1995; Koenig et al.,
1999; Lehmann et al., 2005).
Limitations
Our study has some limitations. First, most of the patients
were taking cholinesterase inhibitors and/or dopaminergic
medication which can influence functional MRI and EEG
signals (Babiloni et al., 2013; Szewczyk-Krolikowski et al.,
2014). Regarding the use of dopaminergic medication we
confirmed that there were no differences in microstate tem-
poral characteristics between patients ON and OFF medi-
cation and no relation to LEDD (Supplementary Table 9).
However, with respect to the use of cholinesterase inhibi-
tors, such a comparison was not possible due to the very
small number of patients in the latter group and this there-
fore remains a limitation. More broadly this is relevant,
given a priori evidence demonstrating a relationship be-
tween disruption to the cholinergic system and cognitive
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fluctuations (Ballard et al., 2002a, b; Pimlott et al., 2006;
Colloby et al., 2017) as well as remediation of this symp-
tom with cholinesterase inhibitor treatment in Lewy body
dementia (Onofrj et al., 2003). The intimate role of cholin-
ergic efferents, for example, from the pedunculopontine nu-
cleus in regulating cortico-thalamic outflow may therefore
apposite in shaping microstate dynamics and contribute to
our observations. Further work will be required to unpick
this conjecture.
In addition, we used non-concurrent EEG-functional
MRI recordings in our study and thus we can only draw
limited conclusions with respect to a causal influence of
network dynamics on microstate characteristics. While the
present results provide an indication of a link between
functional MRI and EEG dynamics, studying concurrent
EEG-functional MRI data in the future will allow us to
draw more concrete conclusions, especially with respect
to the causal relation between microstate characteristics
and large-scale network dynamics.
Conclusions
We report a profound slowing of microstate dynamics in
Lewy body dementia that clearly distinguished this form of
dementia from Alzheimer’s disease and healthy ageing and
which was related to the severity of cognitive fluctuations
in the dementia with Lewy bodies patients. Disturbances to
the precise timing of microstate sequences in Lewy body
dementia may lead to a breakdown of the fractal properties
of the system therefore causing a loss of complexity and
adaptability of the brain network that is crucial for its
healthy functioning and which may in turn be related to
the emergence of transient clinical symptoms such as cog-
nitive fluctuations. Additionally, by using Lewy body de-
mentia as a probe pathology we found a potential link
between large-scale network fluctuations and microstate dy-
namics, suggesting that dynamic interactions within the
cortical-basal ganglia-thalamic loop might play a role in
the modulation of EEG dynamics.
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